Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells

• Type of Material: Article
• Authors: Adilson da Costa, Emory University; Michael Y. Bonner, Karolinska Institutet; Shikha Rao, Emory University; Linda Gilbert, Emory University; Maiko Sasaki, Atlanta Veteran Affairs Medical Center; Justin Elsey, Emory University; Jamie MacKelfresh, Emory University; Jack Arbiser, Emory University
• Language: English
• Date: 2020-02-01
• Publisher: MDPI
• Publication Version: Final Published Version
• Copyright Statement: © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.3390/cancers12020395
• Title of Journal or Parent Work: Cancers
• Volume: 12
• Issue: 2
• Grant/Funding Information: Jack Arbiser is partially funded by: The Reynolds Family Foundation, USA; the Margolis Foundation, USA; NIH AR47901, USA; and a VA Merit Award, USA.
• Keywords: MELANOMA; Oncology; Life Sciences & Biomedicine; GAMMA-SECRETASE; IRF7 PATHWAYS; ACTIVATING MUTATIONS; oncogenic Hras; PRESENILIN-1; CANCER; vascular proliferation; CELLULAR SENESCENCE; driver mutations; NEVI; Science & Technology; angiosarcoma; NOTCH1; AMYLOID PRECURSOR PROTEIN
• Research Categories: Health Sciences, Oncology

Abstract

Lesions with driver mutations, including atypical nevi and seborrheic keratoses, are very common in dermatology, and are prone to senescence. The molecular events that prevent senescent lesions from becoming malignant are not well understood. We have developed a model of vascular proliferation using a temperature-sensitive, large T antigen and oncogenic HRas. By elevating the temperature to 39 °C, we can turn off large T antigen and study the molecular events in cells with the Ras driver mutation. To assess the signaling events associated with the switch from a proliferative to a nonproliferative state in the constant presence of a driver oncogene, SVR cells were cultivated for 24 and 48 hours and compared with SVR cells at 37 °C. Cells were evaluated by Western Blot (WB) gene chip microarray (GC) and quantitative reverse transcription polymerase chain reaction (RT-qPCR). Upon evaluation, a novel phenotype was observed in endothelial cells after switching off the large T antigen. This phenotype was characterized by Notch activation, downregulation of p38 phosphorylation, downregulation of the master immune switch IRF7, and downregulation of hnRNP A0. Switching off proliferative signaling may result in immune privilege and Notch activation, which may account, in part, for the survival of common skin lesions.